ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Coronavirus tests India's vaccine makers in R&D capability

Top player Serum ties up with US company to target product launch by Q2 next year

Indian vaccine manufacturers have been able to offer affordable vaccines to developing countries because they have the capacity to mass-produce. (Source photo courtesy of Zydus Cadila)
ROSEMARY MARANDI and RAJ KUMAR SHARMA, Contributing writers | India

MUMBAI/NEW DELHI -- At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability.

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close